PH15098A - 15-sulfonamidoprostaglandin derivatives - Google Patents

15-sulfonamidoprostaglandin derivatives

Info

Publication number
PH15098A
PH15098A PH24591A PH24591A PH15098A PH 15098 A PH15098 A PH 15098A PH 24591 A PH24591 A PH 24591A PH 24591 A PH24591 A PH 24591A PH 15098 A PH15098 A PH 15098A
Authority
PH
Philippines
Prior art keywords
sulfonamidoprostaglandin
derivatives
sulfonamidoprostaglandin derivatives
Prior art date
Application number
PH24591A
Other languages
English (en)
Inventor
Thomas Ken Schaaf
James Frederick Eggler
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PH15098A publication Critical patent/PH15098A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0041—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PH24591A 1979-09-17 1980-09-16 15-sulfonamidoprostaglandin derivatives PH15098A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/076,520 US4232173A (en) 1979-09-17 1979-09-17 15-Sulfonamidoprostaglandin derivatives

Publications (1)

Publication Number Publication Date
PH15098A true PH15098A (en) 1982-08-10

Family

ID=22132532

Family Applications (1)

Application Number Title Priority Date Filing Date
PH24591A PH15098A (en) 1979-09-17 1980-09-16 15-sulfonamidoprostaglandin derivatives

Country Status (18)

Country Link
US (1) US4232173A (de)
EP (1) EP0025687B1 (de)
JP (1) JPS5951938B2 (de)
KR (1) KR840000964B1 (de)
AR (1) AR225776A1 (de)
AT (1) ATE1858T1 (de)
AU (1) AU518068B2 (de)
CA (1) CA1153368A (de)
DE (1) DE3061160D1 (de)
DK (1) DK392580A (de)
ES (1) ES8106489A1 (de)
FI (1) FI68615C (de)
GR (1) GR70288B (de)
IE (1) IE50266B1 (de)
IL (1) IL61038A (de)
PH (1) PH15098A (de)
PT (1) PT71807B (de)
YU (1) YU236180A (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61126069A (ja) * 1984-11-21 1986-06-13 Res Dev Corp Of Japan プロスタグランジン誘導体
JPS63207015A (ja) * 1987-02-23 1988-08-26 株式会社日立製作所 遮断器装置
US5387608A (en) * 1993-08-17 1995-02-07 Allergan, Inc. Cyclopentane(ene) heptanoic or cyclopentane(ene) heptenoic acid, 2-hydrocarbyl sulfonamidomethyl and derivatives thereof as therapeutic agents
US5607415A (en) * 1994-08-18 1997-03-04 Kimberly-Clark Corporation Flexible absorbent article

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3835179A (en) * 1972-07-24 1974-09-10 American Cyanamid Co Novel 15-substituted prostanoic acids and esters
US4033996A (en) * 1973-04-25 1977-07-05 Merck & Co., Inc. 8-Aza-9-oxo(and dioxo)-thia-11,12-secoprostaglandins
GB1507211A (en) * 1975-02-14 1978-04-12 Ono Pharmaceutical Co Prostaglandin analogues

Also Published As

Publication number Publication date
JPS5651448A (en) 1981-05-09
KR830003415A (ko) 1983-06-20
GR70288B (de) 1982-09-03
KR840000964B1 (ko) 1984-07-02
DE3061160D1 (en) 1982-12-30
DK392580A (da) 1981-03-18
FI68615C (fi) 1985-10-10
FI68615B (fi) 1985-06-28
ES495101A0 (es) 1981-08-16
IL61038A0 (en) 1980-11-30
YU236180A (en) 1983-01-21
CA1153368A (en) 1983-09-06
US4232173A (en) 1980-11-04
EP0025687A1 (de) 1981-03-25
IL61038A (en) 1983-12-30
PT71807A (en) 1980-10-01
EP0025687B1 (de) 1982-11-24
PT71807B (en) 1981-07-02
AR225776A1 (es) 1982-04-30
ES8106489A1 (es) 1981-08-16
IE50266B1 (en) 1986-03-19
FI802904A7 (fi) 1981-03-18
JPS5951938B2 (ja) 1984-12-17
AU6243680A (en) 1981-03-26
IE801927L (en) 1981-03-17
AU518068B2 (en) 1981-09-10
ATE1858T1 (de) 1982-12-15

Similar Documents

Publication Publication Date Title
GB2055813B (en) Aminoalkylbenzene derivatives
GB2054560B (en) Benzylimdiazole derivatives
GB2058765B (en) Deformyltylosin derivatives
NZ193801A (en) 7-amino-cephalosporin derivatives
NZ193799A (en) 3-vinyl-cephalosporin derivatives
GB2046734B (en) 7-(-oximino-pyrazolyl(-acetamido)-cephen derivatives
GB2055818B (en) 3-methyleneazetidine derivatives
GB2056452B (en) Halovincamone derivatives
CU35300A (en) Pyrrholidine derivatives
GB2065111B (en) Decaprenylamine derivatives
GB2052493B (en) Imidazobenzodiazepine derivatives
GB2062464B (en) Eburnamenine derivatives
GB2055368B (en) E-homoeburnane derivatives
GB2053899B (en) Terahydrophthalamide derivatives
MY8400201A (en) Isopropylamino-pyrimidine derivatives
GB2059954B (en) 1-phenethylimidazole derivatives
GB2050377B (en) Pyrazinoquinoxaline derivatives
JPS5651448A (en) 155sulfonamidoprostaglandin derivative
GB2043064B (en) Oximidazoquinoxaline derivatives
GB2065110B (en) Decaprenylamine derivatives
GB2065109B (en) Decaprenylamine derivatives
GB2042508B (en) 3-alkoxy-penem derivatives
GB2122600B (en) Hexahydronaphthacene derivatives
GB2060606B (en) Propionamidoxime derivatives
GB2122186B (en) Oxapenem derivatives